Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Longeveron
Biotech
Incyte, FDA, Sun Pharma and more—Chutes & Ladders
Incyte CEO passes the baton to veteran dealmaker. String of FDA leadership shake-ups continues. Sun Pharma sees future with new North America CEO.
Zoey Becker
,
Gabrielle Masson
Jun 27, 2025 8:30am
Flagship-backed biotechs name new leaders—Chutes & Ladders
Nov 15, 2024 8:30am
With cash runways ending, Nicox and Longeveron plan layoffs
Feb 28, 2024 10:30am
Former BMS R&D chief Vessey jumping to Flagship—Chutes & Ladders
Jul 14, 2023 9:30am
EMD Serono taps new COO—Chutes & Ladders
Jul 7, 2023 9:30am
Billy Dunn departs FDA—Chutes & Ladders
Mar 3, 2023 9:30am